Durability of Complete Response to Intralesional Interleukin-2 for In-Transit Melanoma

BACKGROUND: Intralesional injection of interleukin-2 (IL-2) for in-transit melanoma (ITM) is associated with a high rate of complete response. However, there is a paucity of data on treatment durability and long-term outcomes. OBJECTIVES: To provide long-term data on patients with a complete respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoury, Sami, Knapp, Gregory C., Fyfe, Allison, Monzon, Jose, Temple-Oberle, Claire, McKinnon, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311908/
https://www.ncbi.nlm.nih.gov/pubmed/33529083
http://dx.doi.org/10.1177/1203475420988862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311908/
https://www.ncbi.nlm.nih.gov/pubmed/33529083
http://dx.doi.org/10.1177/1203475420988862

Ejemplares similares